Explore how AI in pharma manufacturing is being deployed with digital twins and predictive tools, which is reshaping CDMO timelines and sponsor expectations.
How to build flexibility into your CGT manufacturing process while maintaining regulatory compliance
MasterControl research shows 40% of advanced therapy executives aren't confident they can meet CGT demand over the next three ...
“We built Valkit.ai to meet the very real needs of life sciences teams burdened by outdated, resource-heavy validation processes,” said Hugh, Devine, CEO of Valkit.ai. “Partnering with CAI amplifies ...
Companies are moving from using AI for distinct operations to applying the technology for control and optimization of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback